Publication:
Switch from Olanzapine Long-Acting Injectable to its Oral Equivalent during COVID-19 Pandemic: a Real World Observational Study

dc.contributor.authorMiron, Ana-Aliana
dc.contributor.authorTeodorescu, Andreea
dc.contributor.authorIfteni, Petru
dc.contributor.authorIrimie, Claudia Alexandrina
dc.contributor.authorDima, Lorena
dc.contributor.authorPetric, Paula-Simina
dc.date.accessioned2025-09-25T15:32:00Z
dc.date.issued2022-03-02
dc.description.abstract
dc.identifier.doi10.1007/s11126-021-09924-9
dc.identifier.issn0033-2720
dc.identifier.issn1573-6709
dc.identifier.urihttps://repository.unitbv.ro/handle/123456789/2192
dc.publisherSpringer Science and Business Media LLC
dc.relation.ispartofPsychiatric Quarterly
dc.titleSwitch from Olanzapine Long-Acting Injectable to its Oral Equivalent during COVID-19 Pandemic: a Real World Observational Study
dc.typeArticle
dspace.entity.typePublication
oaire.citation.issue2
oaire.citation.volume93

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Olz_LAI_COVID_Switch.pdf
Size:
727.56 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.35 KB
Format:
Item-specific license agreed to upon submission
Description: